Targeting the glucocorticoid receptor in breast and prostate cancers

Jacob Kach; Suzanne D. Conzen; Russell Z. Szmulewitz

doi:10.1126/scitranslmed.aac7531

Targeting the glucocorticoid receptor in breast and prostate cancers

Jacob Kach, Suzanne D. Conzen, Russell Z. Szmulewitz

Research output: Contribution to journal › Review article

32 Scopus citations

Abstract

Steroid receptors for androgens and estrogens have essential roles in prostate and breast cancers. Recently, glucocorticoid receptor (GR) activity has also been proposed as having an important role in these cancers. Underscoring the cooperative nature of nuclear receptor activity, data now suggest that GR function in prostate and breast cancers is dependent on the tumor's concomitant androgen or estrogen receptor activity.

Original language	English (US)
Article number	7531
Journal	Science Translational Medicine
Volume	7
Issue number	305
DOIs	https://doi.org/10.1126/scitranslmed.aac7531
State	Published - Sep 16 2015
Externally published	Yes

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1126/scitranslmed.aac7531

Fingerprint Dive into the research topics of 'Targeting the glucocorticoid receptor in breast and prostate cancers'. Together they form a unique fingerprint.

Cite this

Kach, J., Conzen, S. D., & Szmulewitz, R. Z. (2015). Targeting the glucocorticoid receptor in breast and prostate cancers. Science Translational Medicine, 7(305), [7531]. https://doi.org/10.1126/scitranslmed.aac7531

@article{43e2c281e0844b558f37f20944104a13,

title = "Targeting the glucocorticoid receptor in breast and prostate cancers",

abstract = "Steroid receptors for androgens and estrogens have essential roles in prostate and breast cancers. Recently, glucocorticoid receptor (GR) activity has also been proposed as having an important role in these cancers. Underscoring the cooperative nature of nuclear receptor activity, data now suggest that GR function in prostate and breast cancers is dependent on the tumor's concomitant androgen or estrogen receptor activity.",

author = "Jacob Kach and Conzen, {Suzanne D.} and Szmulewitz, {Russell Z.}",

year = "2015",

month = sep,

day = "16",

doi = "10.1126/scitranslmed.aac7531",

language = "English (US)",

volume = "7",

journal = "Science Translational Medicine",

issn = "1946-6234",

publisher = "American Association for the Advancement of Science",

number = "305",

}

TY - JOUR

T1 - Targeting the glucocorticoid receptor in breast and prostate cancers

AU - Kach, Jacob

AU - Conzen, Suzanne D.

AU - Szmulewitz, Russell Z.

PY - 2015/9/16

Y1 - 2015/9/16

N2 - Steroid receptors for androgens and estrogens have essential roles in prostate and breast cancers. Recently, glucocorticoid receptor (GR) activity has also been proposed as having an important role in these cancers. Underscoring the cooperative nature of nuclear receptor activity, data now suggest that GR function in prostate and breast cancers is dependent on the tumor's concomitant androgen or estrogen receptor activity.

AB - Steroid receptors for androgens and estrogens have essential roles in prostate and breast cancers. Recently, glucocorticoid receptor (GR) activity has also been proposed as having an important role in these cancers. Underscoring the cooperative nature of nuclear receptor activity, data now suggest that GR function in prostate and breast cancers is dependent on the tumor's concomitant androgen or estrogen receptor activity.

UR - http://www.scopus.com/inward/record.url?scp=84941755779&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941755779&partnerID=8YFLogxK

U2 - 10.1126/scitranslmed.aac7531

DO - 10.1126/scitranslmed.aac7531

M3 - Review article

C2 - 26378243

AN - SCOPUS:84941755779

VL - 7

JO - Science Translational Medicine

JF - Science Translational Medicine

SN - 1946-6234

IS - 305

M1 - 7531

ER -